Related Experiment Video
Updated: May 2, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
Published on: November 1, 2015
Systemic lupus erythematosus: one year in review 2025
Angela Elia1, Dina Zucchi1, Ettore Silvagni2
1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
Abstract:
This review highlights key advancements in systemic lupus erythematosus (SLE) research during 2024, covering pathogenesis, novel therapies, biomarkers, and clinical outcomes. Notable findings include new insights into immune dysregulation, promising therapeutic targets, and real-world data confirming the efficacy of anifrolumab and belimumab. Advances in biomarkers enhance disease monitoring, while multidisciplinary approaches improve reproductive outcomes and quality of life. These developments contribute to refining SLE treatment strategies and patient management.
Related Concept Videos
iPS Cell Differentiation
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...

